Unknown

Dataset Information

0

Selective mtDNA mutation accumulation results in beta-cell apoptosis and diabetes development.


ABSTRACT: To test the hypothesis that somatic mitochondrial (mt)DNA mutation accumulation predisposes mice to beta-cell loss and diabetes development, transgenic mice expressing a proofreading-deficient mtDNA polymerase-gamma under the control of the rat insulin-1 promoter were generated. At 6 wk of age, mtDNA mutations reached 0.01% (1.05 mutations/10,000 bp) in islets isolated from transgenic mice. This mutational burden is associated with impaired glucose tolerance and a diabetes prevalence of 52% in male transgenic mice. Female transgenic mice maintain slightly elevated fasting glucose levels, mild glucose intolerance, and a diabetes prevalence of 14%. Diabetes in transgenic animals is associated with insulin insufficiency that results from a significant reduction in beta-cell mass. Importantly, apoptosis of beta-cells is increased 7-fold in female and 11-fold in male transgenic mice compared with littermate controls. These results are consistent with a causative role of somatic mtDNA mutation accumulation in the loss of beta-cell mass and diabetes development.

SUBMITTER: Bensch KG 

PROVIDER: S-EPMC2670628 | biostudies-literature | 2009 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Selective mtDNA mutation accumulation results in beta-cell apoptosis and diabetes development.

Bensch Kenneth G KG   Mott Justin L JL   Chang Shin-Wen SW   Hansen Polly A PA   Moxley Michael A MA   Chambers Kari T KT   de Graaf Wieke W   Zassenhaus H Peter HP   Corbett John A JA  

American journal of physiology. Endocrinology and metabolism 20090121 4


To test the hypothesis that somatic mitochondrial (mt)DNA mutation accumulation predisposes mice to beta-cell loss and diabetes development, transgenic mice expressing a proofreading-deficient mtDNA polymerase-gamma under the control of the rat insulin-1 promoter were generated. At 6 wk of age, mtDNA mutations reached 0.01% (1.05 mutations/10,000 bp) in islets isolated from transgenic mice. This mutational burden is associated with impaired glucose tolerance and a diabetes prevalence of 52% in m  ...[more]

Similar Datasets

| S-EPMC5031544 | biostudies-literature
| S-EPMC2665776 | biostudies-literature
| S-EPMC5333061 | biostudies-literature
| S-EPMC3981675 | biostudies-literature
| S-EPMC5038573 | biostudies-literature
| S-EPMC3781408 | biostudies-literature
| S-EPMC7790827 | biostudies-literature
| S-EPMC7441052 | biostudies-literature
| S-EPMC8262350 | biostudies-literature
| S-EPMC9475022 | biostudies-literature